trifluoperazine has been researched along with Parkinson Disease, Secondary in 20 studies
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
Excerpt | Relevance | Reference |
---|---|---|
"Dysphagia is a potentially life-threatening complication of drug-induced parkinsonism." | 1.29 | Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report. ( Bashford, G; Bradd, P, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (90.00) | 18.7374 |
1990's | 1 (5.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (5.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sadananda, SK | 1 |
Holla, B | 1 |
Viswanath, B | 1 |
Narasimha, A | 1 |
Sebastian, A | 1 |
Math, SB | 1 |
Chandrashekar, CR | 1 |
Sheppard, C | 1 |
Merlis, S | 1 |
Keshavan, MS | 1 |
Narashimha Rao, IV | 1 |
Narayanan, HS | 1 |
Bashford, G | 1 |
Bradd, P | 1 |
Sahoo, RN | 1 |
Mitra, GC | 1 |
Mohanty, PC | 1 |
Stokes, HB | 1 |
Martin, IC | 1 |
Crowley, TJ | 3 |
Hoehn, MM | 3 |
Rutledge, CO | 3 |
Stallings, MA | 2 |
Heaton, RK | 1 |
Sundell, S | 2 |
Stilson, D | 1 |
Srikant, G | 1 |
Kantharaj, L | 1 |
Rao, PR | 1 |
Van Woert, MH | 2 |
Sethy, VH | 1 |
Ambani, LM | 2 |
Bordeleau, JM | 1 |
Tétreault, L | 1 |
Morrison, AB | 1 |
Webster, RA | 1 |
Bowers, MB | 1 |
Demars, JP | 1 |
Zolotnitskii, RI | 1 |
Kutsenok, BM | 1 |
Gastev, MD | 1 |
Ridges, AP | 1 |
Harper, P | 1 |
Fischer, R | 1 |
Knopp, W | 1 |
Griffin, F | 1 |
Ekdawi, MY | 1 |
Fowke, R | 1 |
2 trials available for trifluoperazine and Parkinson Disease, Secondary
Article | Year |
---|---|
Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Delayed-Action Preparat | 1975 |
Neuromuscular effects of long-term phenothiazine medication, electroconvulsive therapy and leucotomy.
Topics: Aged; Chlorpromazine; Clinical Trials as Topic; Electric Stimulation Therapy; Female; Haloperidol; H | 1966 |
18 other studies available for trifluoperazine and Parkinson Disease, Secondary
Article | Year |
---|---|
Effectiveness of electroconvulsive therapy for drug-induced parkinsonism in the elderly.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Electroconvulsive Therapy; Humans; Male; Middle Aged | 2013 |
Drug-induced extrapyramidal symptoms: their incidence and treatment.
Topics: Chlorpromazine; Chlorprothixene; Extrapyramidal Tracts; Female; Fluphenazine; Humans; Male; Parasymp | 1967 |
Rate of blinking may predict neuroleptic-induced parkinsonism.
Topics: Blinking; Humans; Parkinson Disease, Secondary; Trifluoperazine | 1983 |
Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report.
Topics: Aged; Deglutition Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administrat | 1996 |
Irreversible drug induced parkinsonism (two case reports).
Topics: Adult; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Phenothiazines; Prochlorperazine; Tr | 1975 |
Trifluoroperazine for the symptomatic treatment of chorea.
Topics: Acute Disease; Adolescent; Adult; Cerebrovascular Disorders; Child; Chorea; Drug Evaluation; Female; | 1975 |
Dopamine excretion and vulnerability to drug-induced Parkinsonism. Schizophrenic patients.
Topics: Adult; Dopamine; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease, Secondary | 1978 |
The Parkinsonian syndrome and its dopamine correlates.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Dopamine; Extrapyramidal Tracts; Female; Homovanillic A | 1977 |
Low urinary dopamine and prediction of phenothiazine-induced Parkinsonism: a preliminary report.
Topics: Adult; Dopamine; Female; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease, Secondary; | 1976 |
Two cases of parkinsonism developing after industrial exposure to trifluperazine.
Topics: Adult; Humans; Male; Occupational Diseases; Parkinson Disease, Secondary; Trifluoperazine | 1986 |
Effect of phenothiazines on central cholinergic activity.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Brain Chemistry; Chlorp | 1974 |
[Study of extrapyramidal manifestations induced by neuroleptics].
Topics: Antiparkinson Agents; Chlorpromazine; Drug Synergism; Extrapyramidal Tracts; Fluphenazine; Haloperid | 1972 |
Drug-induced experimental Parkinsonism.
Topics: Animals; Atropine; Benztropine; Butyrophenones; Cats; Chlorpromazine; Dose-Response Relationship, Dr | 1973 |
Physostigmine effects on phenothiazine-induced extrapyramidal reactions.
Topics: Adult; Antiparkinson Agents; Chlorpromazine; Drug Hypersensitivity; Extrapyramidal Tracts; Female; H | 1973 |
[On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia].
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Catatonia; Chlorpromazine; Cognition Disorders; Hall | 1969 |
Pink spot--is it a drug artefact?
Topics: Amitriptyline; Amobarbital; Chlorpromazine; Chromatography; Haloperidol; Humans; Mental Disorders; P | 1970 |
Taste sensitivity and the appearance of phenothiazine-tranquilizer induced extrapyramidal symptoms.
Topics: Extrapyramidal Tracts; Female; Humans; Movement Disorders; Parkinson Disease, Secondary; Phenothiazi | 1965 |
A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.
Topics: Adolescent; Adult; Chlorpromazine; Haloperidol; Humans; Middle Aged; Orphenadrine; Parasympatholytic | 1966 |